Investigational drug 0431-024

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational drug 0431-024, covering 2009-12-22 to 2009-12-22. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) [Phase 3]